Progressive divergent shifts in natural and induced T-regulatory cells signify the transition from undifferentiated to definitive connective tissue disease

被引:23
作者
Szodoray, Peter [1 ]
Nakken, Britt [2 ]
Barath, Sandor [1 ]
Gaal, Janos [3 ]
Aleksza, Magdolna [1 ]
Zeher, Margit [1 ]
Sipka, Sandor [1 ]
Szilagyi, Anna [1 ]
Zold, Eva [1 ]
Szegedi, Gyula [1 ,4 ]
Bodolay, Edit [1 ]
机构
[1] Univ Debrecen, Div Clin Immunol, Dept Med 3, H-4012 Debrecen, Hungary
[2] Univ Debrecen, Dept Biochem & Mol Biol, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary
[3] Kenezy Cty Hosp, Dept Rheumatol, Debrecen, Hungary
[4] Hungarian Acad Sci, Res Grp Autoimmune Dis, Budapest, Hungary
关键词
clinical signs; cytokines; definitive connective tissue diseases; regulatory T cells; undifferentiated connective tissue disease;
D O I
10.1093/intimm/dxn056
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The objectives of the study is to determine clinical signs and distribution of peripheral T-cell subsets, B cells and T regulatory cells in patients with undifferentiated connective tissue disease (UCTD) and during the development toward well-established connective tissue diseases (CTD). The methods include 46 patients with UCTD were followed and investigated for differentiation into defined CTDs for 2 years. Cell subsets were determined on the basis of cell surface markers, intracellular cytokine production by flow cytometry and serum cytokine levels by ELISA. The results are as follows: 45.6% of UCTD patients developed into a defined CTD. The number and percentage of activated T cells, memory T cells and NKT cells were increased in patients compared with controls. In addition, in patients with UCTD, the percentage of CD4+/IFN gamma+ T(h)1 was significantly higher compared with controls and further increased in patients that developed CTDs. The percentage and absolute number of CD4+CD25+Foxp3+ regulatory T cells (Tregs) were diminished in UCTD patients compared with healthy controls, while the number of CD4+/IL-10+ Tregs increased. The conclusions are Overproduction of IFN gamma and the decrease of natural (Foxp3+) Tregs seem to be characteristic features of UCTD patients. The increased IL-10 production of CD4+ T cells might be a compensatory suppressive mechanism; however, it is probably not able to balance the overproduction of IFN gamma and the observed decrease of Foxp3+ Tregs. The shift toward T(h)1 with increased IFN gamma production in patients with UCTD combined with the degree of immunoregulatory disturbances characterized by the progressive divergent shifts in natural and induced T-regulatory cell populations signify the transition from undifferentiated to definitive CTD.
引用
收藏
页码:971 / 979
页数:9
相关论文
共 38 条
[1]   Unclassified or undifferentiated connective tissue disease [J].
Alarcón, GS .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2000, 14 (01) :125-137
[2]   PRELIMINARY CRITERIA FOR THE CLASSIFICATION OF SYSTEMIC-SCLEROSIS (SCLERODERMA) [J].
不详 .
ARTHRITIS AND RHEUMATISM, 1980, 23 (05) :581-590
[3]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[4]   Regulatory T cells in peripheral blood of patients with mixed connective tissue disease [J].
Barath, S. ;
Sipka, S. ;
Aleksza, M. ;
Szegedi, A. ;
Szodoray, P. ;
Vegh, J. ;
Szegedi, G. ;
Bodolay, E. .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2006, 35 (04) :300-304
[5]   Mouse CD1-specific NK1 T cells: Development, specificity, and function [J].
Bendelac, A ;
Rivera, MN ;
Park, SH ;
Roark, JH .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :535-562
[6]   Natural killer cells in antiviral defense: Function and regulation by innate cytokines [J].
Biron, CA ;
Nguyen, KB ;
Pien, GC ;
Cousens, LP ;
Salazar-Mather, TP .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :189-220
[7]  
Bodolay E, 2003, CLIN EXP RHEUMATOL, V21, P313
[8]  
Bodolay E, 2002, J RHEUMATOL, V29, P2136
[9]   POLYMYOSITIS AND DERMATOMYOSITIS .1. [J].
BOHAN, A ;
PETER, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (07) :344-347
[10]   AUTOIMMUNITY, MICROBIAL IMMUNITY AND THE IMMUNOLOGICAL HOMUNCULUS [J].
COHEN, IR ;
YOUNG, DB .
IMMUNOLOGY TODAY, 1991, 12 (04) :105-110